Maternal Serum CA125 is Not a Second Trimester Marker for Down's Syndrome

K. Spencer

DOI: https://doi.org/10.1177/000456329102800318

1991-03-01

Abstract:Check et ul.’ reported in 1990, three women with very elevated, early first trimester CA125 concentrations, who subsequently spontaneously aborted in the late first or early second trimester, and in whom the products of conception showed chromosomal abnormalities (Trisomy 12 and 13, 45X, Trisomy 21). Check et al.’ concluded that a high maternal serum CAl25 concentration might be predictive of an abnormal karyotype. Following this initial observation I have considered the possibility that CA125, if truly an indicator of abnormal karyotype, may still be elevated in viable second trimester pregnancies. Furthermore, if this was the case, then it might prove to be a useful screening test for Down’s syndrome (Trisomy 21) or as an adjunct to other serological marker^.^,^ In order to test the hypothesis, 25 maternal serum samples from Down’s syndrome pregnancies were identified from stores of abnormal samples, along with five unaffected control cases for each Down’s case. The controls were matched for gestational age (k 3 days), maternal age (k 6 months) and a length of storage (k 1 month). A further series of samples, covering the gestational age range 16-20 weeks, were chosen at random from our pool of normal singleton pregnancies. An additional series of samples was identified in which the pregnancy ended in intra uterine death (10 cases) or spontaneous abortion (10 cases). All samples were analysed for CA125 using a solid phase two site monoclonal immunoradiometric assay (ELSA-CA125, CIS (UK) Ltd, High Wycombe, UK) according to the manufacturer’s protocol. Since there is no International Standard for CA125, the results were expressed in arbitrary units (U/mL) as determined by the kit manufacturer. The samples were spread evenly over five different assay batches and the between assay precision was found to be 3.8% coefficient of variation at 119 U/mL and 8.2% at 20 U/mL. To allow for possible variation in CA125 levels with gestational age, all values were expressed as multiples of the median (MOM) value for unaffected pregnancies of the same gestational age. Table 1 summarizes the data showing the variation of CA125 with gestational age. The data showed only minor variation; only the change from 16 to 17 weeks being possibly statistically significant ( 0 . 0 5 > P > 0 . 0 2 ) using t tests of significance. The combined median for all the normal data (n = 231) was 19.4 U/mL. There was no correlation of CA125 with maternal age (r=0.00199) .